LYRICA treatment method was connected to creatine kinase elevations. Mean variations in creatine kinase from baseline to the utmost worth were being 60 U/L for LYRICA-treated people and 28 U/L for the placebo clients. In all controlled trials in adult individuals across multiple affected person populations, 1.five% of clients on LYRICA and 0.seven%